Encapsulated Cell Therapies and Encapsulation Technologies Market
A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of administration
102
views

To order this 500+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030-/249.html

 

Key Inclusions

§  A detailed assessmentof the current market landscape of encapsulated cell therapies and affiliatedtechnologies, highlighting various target disease indications, phase ofdevelopment, encapsulation method, type of cells / API, and route ofadministration, along with information on various stakeholder companies thatare developing novel encapsulation methods / techniques for use in storage andtransportation of cells, as well as other applications.

§  Comprehensiveprofiles of industry players that are currently engaged in the preclinical /clinical development of their proprietary encapsulated cell therapies,featuring an overview of the company, its financial information (if available), and a detaileddescription of its product(s), highlighting mechanism of action, currentdevelopment status, and key preclinical / clinical trial results. Each profilealso includes a list of recent developments, highlighting the key milestonesachieved, partnership activity, and the likely strategies that may be adoptedby these players to fuel growth in the in the foreseen future.

§  An in-depth analysisof the patents that have been published related to cell encapsulationtechnologies, since 2013. The analysis also highlights the key trendsassociated with these patents, across patent type, regional applicability, CPCclassification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks andvaluation.

§  A comprehensiveclinical trial analysis of completed, ongoing and planned studies of variousencapsulated cell therapies. The analysis highlights the key trends associatedwith these clinical studies across various parameters, such as trial startyear, trial status, phase of development, leading industry and non-industryplayers (in terms of number of trialsconducted), study design, target therapeutic area, key indications, studyfocus, clinical endpoints, and enrolled patient population and regionaldistribution of trials.

§  An analysis of thepartnerships that have been established in the domain in the period 2013-2018,covering R&D collaborations, licensing agreements, mergers andacquisitions, product development and / or commercialization agreements,manufacturing agreements, clinical trial agreements, process developmentagreements, and other relevant deals.

§  An analysis of theinvestments made at various stages of development, such as seed financing,venture capital financing, debt financing, grants, capital raised from IPOs andsubsequent offerings received by companies that are focused in this area.

§  A detailed study onthe various grants that have been awarded to research institutes in this field.

§  An analysishighlighting potential strategic partners (forinstance, manufacturers) for encapsulated therapy developers based onmultiple parameters, such as therapeutic focus overlap, cell type overlap,research programs, existing collaborations, and developer strength.

 

The report also features the likely distribution of thecurrent and forecasted opportunity across important market segments, mentioned below:

§  Type of licensing deal payment

§   Upfront payment

§   Milestone payment

 

§  Therapeutic area

§   Metabolic disorder

§   Neurological disorder

§   Ophthalmic disorder

§   Oncological disorder

 

§  Target disease indication

§   Ataxia telangiectasia

§   Breast cancer

§   Diabetes

§   Glaucoma

§   Head and neck cancer

§   Macular telangectasia

§   Pancreatic cancer

§   Parkinson's disease

§   Retinitis pigmentosa

 

§  Type of encapsulation material used

§   Alginate-based microcapsule

§   Cellulose hydrogel

§   Medical-grade plastic

§   Red blood cell

 

§  Key geographical region

§   North America

§   Europe

§   Asia-Pacific and rest of the world

 

To request sample pages, please visit this - https://www.rootsanalysis.com/reports/249/request-sample.html

 

Key Questions Answered

§  Whatare the prevalent R&D trends related to cell encapsulation technologies?

§  Whichclinical conditions can be treated using encapsulated cell therapy products?

§  Whatare the key challenges faced by stakeholders engaged in this domain?

§  Whatare the key technology platforms that leverage the concept of cellencapsulation?

§  Whoare the leading industry and non-industry players in this market?

§  Whatare the key geographies where research on encapsulated cell therapies is beingconducted?

§  Whoare the key investors in this domain?

§  Whoare the key thought leaders with expertise in cell encapsulation technologies?

§  Whatkind of partnership models are commonly adopted by industry stakeholders?

§  Whoare the potential strategic partners (for instance, manufacturers)for encapsulated therapy developers?

§  Howis the current and future market opportunity likely to be distributed acrosskey market segments?

§ What are the factors that are likely to influence theevolution of this upcoming market?

 

You may also be interested in the following titles:

1.     Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal andContinuous Delivery Devices

2.     Endocannabinoid System Targeted Therapeutics Market, 2020-2030

3.     Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

 

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com